Research and commercial isotope production at TRIUMF

Journal Article · Mon Dec 01 04:00:00 EST 1997 · Transactions of the American Nuclear Society

OSTI ID:552685

Stevenson, N R ^[1]; Larabie, P L ^[2]

---

1. TRIUMF, Vancouver (Canada)
2. MDS Nordion, Inc., Vancouver (Canada)

The environment present at commercial facilities for the production of radioisotopes is usually unsuited to that required for truly innovative and cutting-edge research. At TRIUMF, however, a unique relationship exists between a federal research laboratory (TRIUMF) and a commercial producer of radioisotopes (MDS Nordion Inc.) that does allow for both of these aspects. In this partnership, the main role of TRIUMF is to operate the commercial compact cyclotrons and the associated targetry and to produce radioisotopes on the large 520-MeV main cyclotron. MDS Nordion subsequently processes and distributes the radioactive products to customers. TRIUMF`s expertise in cyclotron and targetry technology is constantly being applied to improve the existing isotope production systems. Completely new cyclotron and targetry systems have also been developed for commercial radioisotope production, such as the TR30 cyclotron and its upgrade and the universal encapsulated target system for isotope production.

• OSTI ID: 552685
• Report Number(s): CONF-971125--
• Journal Information: Transactions of the American Nuclear Society, Journal Name: Transactions of the American Nuclear Society Vol. 77; ISSN 0003-018X; ISSN TANSAO
• Country of Publication: United States
• Language: English

Related Subjects

43 PARTICLE ACCELERATORS
DESIGN
ISOTOPE PRODUCTION
RESEARCH PROGRAMS
TRIUMF CYCLOTRON